Legal and administrative Informatlon
Trustees
Dl8go du Monceau de Bergendal
Duncanjodrell
CarollneArtIs
Re0stered offlee
49 Stjames s Street
London
SWIA IAH
Re8lster•d number
272818
Chartor￿1 accountsnl
Melissa Foux nr8313878
$6 Fianders Road
Londtsn W4 ING
Bankers
Coutts&Co
440 Strand
London
W¢2ROQS

Trustee's report 31 December 2025
The Trustee5 present thelr report along with the accounts of the Frlends of EORTC Ithe Charity) for the year
ended 31 December 2025. The accounts have been prepared in accordance with the accountlng polkies set out
on pages 16 to 18 and complywith the charity's trustdeed, the CharitiesAct 2011 and'Accounting and Reporting
by Charities.. Statement of Recommended Practice applitable to charities preparing their accounts in accordance
with the Flnancial Reportin8 Standard applicable In the United Kingdom and Republic of Ireland {FRS 1021.
Strurturep governance and management
The Charty was established under a Trust Deed In 1976 and is registered with the Charfty Commission under
charity number 272818.
The Chairman. Comte Diego du Monceau de 8eTgendal, was appointed a trustee in 2015 on the retirement of
the then Chairman, Sir Christopher Mallaby. His fellow trustee, Lady Solti was apk)ointed a trustee in 1998, and
Mr Edward Chandler was appointed on 7 October 2020, coinciding with the resignation of Mrs Victoria Agnew
who had dedicated 22 years to her role with the organisation. Pr. Duncan Jodrell was appointed on 10 November
2021 to replace Lady Solti. Mrs Caroline Artis was appointed on 7 October 2022. Mr Edward Chandler resigned
on March 1, 2023. There 15 no time limit on the tenure of the trustees. The trustees meet twice a year.
The Board keeps the Skill requirements for t￿ Trustee Body under review and if a trustee permanently retlres
or addhional trustees are required, the Board would put in place appropriate procedures to recruit the new
trusteelsl. The Board would 3150 ensure that appropriate induction and trainln£ is provided to all new trustees.
Statement of trustees, resp¢nsibilities
The trustee5 are responsible for preparing the trustee5' report and accounts In accoidance with applicable law
and United Kingdom Accounting Standard5 Iunlted Kingdom Generalty Accepted Accounting Practice).
The law applicable to char6tles in England and Wales requires the trustees to prepare accounts for each fiscal
year whlch 86ve a true and fair view of the state of affairs of the charlty and of the incoming resources and
applicatlon of resources of the charity forthat perlod. In preparing these accounts. the trustee5 are requlred to..
select suitable accounting policies and then apply them consistently..
observe the methods and principles in the Charities SORP,.
make judgements and estimates that are reasonable and prudent;
state whether applicable UK accounting Standards have been followed, subject to any materlal
departures disclosed and explained in the accounts,. and
prepare the accounts on the going concern basi5 unles5 It is inapproprlate to presume that the charty
will continue in operation.
The trustees are responsible for keeping proper accounting records that disc105e with reasonable accurary at
any time the financial position of the charity and enable them to ensure that the accounts comply with the
Charities Act 2011. the Charity IAtcount5 and Reportsl Regulations 2(K)8 and the provisions of the trust deed.
They are also responslble for safeguarding the assets of the charlty and hence for taking reasonablè step5 for
the prevention and detettion of fraud and other irregularities.
Rlsk management
The Charity does not hève any employees. significant contracts or material investments nor is the Charitv
dependent on grant fundlng from external sourtes to rnaintsin its charitable attivities. As a result of these
limited activities, the Charlty is exposed to lew slgnificant risks. The prlntipal risk faced by the Charity would be
the fallure to generate suffident donations to cover the costs of or8anising a fundralsing event. This is mStigated
by the Charlty, wherever posslble, by raising fund5 In advance of costs being incurred,. carefully planning its

fundraising events,. targetlng known supporters of the Charity and closely monltoring fundraising tosts and
donations.
Objectives and Acti¥rtles
EORTC was set up in 1962 by leadin8 cancer specialists in the EU and Swltzerland In order that research on
treatment of cancer could be co-ordinated and carried out on a European scale, thereby avolding duplScation
and achieving economies of time and money.
The primary objert rif the Charlty. as stated In Its goveming dotument, is to support the chadtsble objects and
purposes of EORTC Can￿r Research Fund AISBL IECRFI, a charity registered in Belgium. The ECRF was
estsblished in 1976, as The EORTC Foundation. Thls charitable trust was established to support the artivities of
the EORTC.
The ECRF supports the activities of the EORTC through annual grant payments to the EORTC which are used by
the EORTC to fund researth into cancer treatments. The Frlends of EORTC sUPPOrts the ECRF by organising
fundraislng events in the UK and by a malor fundraisin8 initiative. The funds raised by the Frlends of EORTC are
then used to support the activities of the ECRF. The Friends of EORTC makes donations to EORTC on an ad- hoc
basis, as determined by the Trustees.
Achlevements and Performance
Finan¢lal revlew
The Income of the charty declined over that of the previous year. however a major fundraislng initiative
continued, and private donations were received In 2025. The charity received donations from its supporters
mountinE to £154,83612024- £40,1221.
Total expenditure.. £ 152,62812024- £ 42,0571.
The charfjty remains financially stable with a small surplus.
Interest and forel8n exchange
The Charity earned £245 in interest In 202512024-£5571 and booked no foreign exchange gains12024- none).
The Boots Group* TBG Ifonnerly known as Walgreens Boots Alllance, WBA}
EORTC Cancer Research Fund Iformerly the EORTC Charitable Trust) has been in partnership with The 800ts
Group (formerly WBA, then Alliance Boots) Since late 2011. The partnership focused on creating the first pan-
European biobank In advanced colorectal cancer, now fully operational in Dresden. Formerly known WBA
commltted to raislngC5 million Dver five years to supportthis key research infrastructure. Sclentific planning for
the project, named SPECTAcolor, began in 2012 with the development of biobanking facilities and identification
of partlcipatlng hospitals.
The success of SPECTAcolor led EORTC to expand to other cancer types, culmlnatinÉ In 2018 with the launch of
SPECTA. a unified platform for all cancers, including rare ones, with a central bSobank in Luxembourg. That same
year, the Group renewed its 5UPPOrt through a new £5 million. five-year agreement, reaffimiln8 SPECTA'S
position as a leading translational research infrastructure
In Ortober 2022, the Group and EORTC launched a new three-yearfundraising effort to raise (1.8 milllon for the
OligoRARE study and the E -RADlatE platfomi. which alms to define optimal radiation theropy practices for
future c15nical standards.
E'.RADlatE is the only p?n-European platform dedicated to radiation oncolobry research, integrating clinlcal data
with diagnostic imagin& treatment data, economic outcomes, and patient-reported experiences to enhance
patient-centred ca￿.

The platform indudes several obseryational cohort studies and clinical trlals:
Ollgocare IEORTC 1822-RPI.' the first attivated cohort. focuses on patients with oligometastatic disease
(cancer spread to 3 limlted number of organs). aiming to identify factors influencing SLtrvival after
radical radiotherapy. Cancer types studied include breast, lun& prostate, and colorectsl.
Recaie IEORTC 2011-RPI.' collects real-world data on hlgh-dose re-IrradiatSon in cases of recurrence or
secondary cancers. It aims to provide evidence on efflcacy and Safety of re-treatment in the modern
radiotherapy era.
Oli8oRARE IEORTC 19451.. a randomized clinical trial evaluatin8 whether SABR (Stereotactic Ablative
Body RadSotherapyl Improve5 survival ￿mpared to standard care in patients with oligometastatlc rare
cancers.
SPRI?￿ IEORTC 23871- 15 the first pan-European Trial wlthin Cohorts ITwiC51, leveraging real-world data
from the ol1goca￿ cohort to evaluate treatment strategies for patients wlth ollgometa5tatic breast,
prostate. lung, and co10￿cta1 cancers. The study aims to determine whether a single fraction of
stereotartic body radiotherapy ISBRT) can be as effective as multl-frattion SBRT. potential￿ reduclng
treatment burden vA)ile improving patient experience and quality of lrfe.
E -RADlatE Supports radiOtherap￿S role as a cornerstone of carkcer care, used by half of all patients during
treatment. 8y leveraging advanced technology and structured dats collectlon, the platform contributes to
re(luclng inequities in ¢are and Improving outcomes across Europe.
Alllance HealthcaTe (to be renamed Cen¢oral
In June 2021, Walgreens Boots Alllance sold its Alliante Healthcare businesses to Amerlsource8ergen, now
renamed Cencora. Alllance Healthcare. now a wholly owned subsldiary of Cencora. supported the SPEcfA
platform under its new ownership with half of the Initial pledge be raised by the end of the agreement in 2023.
In 2024, Cencora contrlbuted an additional SIOOK towards the plarform. The funds raised through the
partnership are estimated to cover the current artivitles of the platform until 2027.
In 2025, with the departure of Mrs Barra from the Cencora Board, ECRF recefved a donation of $5,OW in honour
of her seNices to their Board. The fund5 were allocated to E2-RADlatE ￿lating activities.
Alliance Healthcare (soon to be renamed Cen¢ara) contributlon5
From June 1st, 2021, to December 2024. 2023, Alliance Healthcare has raised a total of Q,192,401.24.
Honouring the origlnal agreement between the former WBA and EORTC.
AMRC- Assoclatlon of Medical Research Charltl
Since October 2014, the Friend5 of EORTC has been a member of AMRC. This membership provides tlear benefit5
for EORTC and for the costs related to its intemational clinical studies belng opened or adopted in the UK.
Membership of AMRC laudlted on an annual basis) helps the EORTC to quallfy as ellgible under the UK NHS
ACORD Programme under whlch certain clinical research costs are met by the National Health Service.
Under ACORD, AMRC charitle5 that fund In open competition do not have to pay these costs. The work will be
done by the NIHR Clinical Research Networks or will be covered by the infrastructure 5UPPOrt funding golng to
NHS trusts and universities. EORTC, through the Friends of EORTC. is in good stsnding for supportfrom the NIHR
and NHS for other study related costs as described above.
UK Llalson Office
A Liaison Office has been established in the UK between the Natlonal Cancer Research Institute INCRII, EORTC
and CR-U¥ to promote better communications between these three organisations and to facilltate the adoption
of EORTC'S international studies in the UK and the extension of UK Studies Into Europe. The Friends of EORTC
supports this initlative by currèntly contrlbuting one thlrd of the costs of the salary of the Lialson Officer, based
at the University of Leed5. Since 2017. the costs of the Liaison Office in Leed5 have been shared bètween EORTC
and CR-UK.

Investment powers. polky, and pertormance
The Charity does not hold investments other than cash held on an interest bearrng deposlt on a short-term basis.
These funds are held in the Charity'5 bank account, held by Coutts.
Grant makln8 pollry
The Charity makes grants to the EORTC and to the EORTC Cancer Research Fund and for fellowships, a5 dlrect
rants or on an ad-hoc basls.
Reserves
The Charity makes grants to the EORTC as cash becomes available, retainin8 sufficient funds to tover the
potential outgoings associated with future fundraising events. The Charity does not enter on-going
commitments and therefore does not need to ensure a steady flow of income. For this reason, the trustee5 do
not consider it appropriate to maintain a target level of re5etves.
The fvnds ralsed by the Charity are held as deposlts on call accounts until such time that the Trustees wish to
make grants or donations directly to the EORTC to support their ongolng activities.
Golng concern
The Trustees of the charity have detemiined that there are no materlal uncertainties related to events or
conditlons that may cast significant doubt on the abllity of the tharity to continue as a going concern. The
trustees are of the opinion. based on avallable information at the date of approval of the financial statements.
that the charity woll have su)Ticient ￿$0￿r(est0 meet its liabilities asthey fall due. They do not believe thattherè
are concerns regardlng the charlty's abilty to continue as a going concern.
Approved by order of the Trustees
Chairman
Die80 du Monceau
0111012026
Date

Ind•p•ndont oxamln•r* r•port to th• lrn8ts•8 ofth• Frl•nd8 of EORTC
I report to the trustee8 on rny examlnatlon of the accounts of the Frlends ot EORTC for
the year ended 31 December 2025.
Ro•ponJlblUtIM and ba8ls of r•pon
A3 the charity trustees of the Trustyou are responslble lorth8 preparatlon of the
accounts in accordance wlth the requlrements otthe Charftles Act 2011 {'the Acf).
l report In respect of my exemlnatlon of the Tru8t s accounts carrfed out under sectlon
145 of the 2011 Act end in carrying out my ex8minatlon I have followed ati the
8ppIIc8bie Dlrèctlons glven tythe Charltyccmmlsslon under8ectlon 145{5)(b) oftha
Ind•pondent oxamln•rts 8tat•m•nt.
I completed my exarnln8tlon. I conflrm that no m8t8rial matters have come to my
attention In connectlon wlth the examlnatlon 8lvlng me cau80 to beueve that In ary
materlal respect:
1. 8ccountlng record8 were not kept In respect of the Trust 88 required ty section 130 01
the ACL. or
2. the accounts do not accord with those records: or
3. the accounis do not compty wlth the appllcable requSrements eoncernlngthe form
and content of accounts set out Sn the Charities (Accounts and Report8) Regulatlons
2008 otherthan any requlrement thatthe accounts give a ?rue and fair vlewwhlch18 not
a matter consldéred a8 part of an independent examlnatlon.
I have no concems and have come across no other matter8 In ¢onne¢tlon wlth the
&Yamination to whlch attention should be drawn in thls report in order to enable a
proper underst8ndlng of thè accounts to be reached.
Signed."
Name: Melissa Foux
Relevant professlon81 quaifflcatlon or membership of professlonal bodies (if any):
Chartered Accoumant ICAEW Membership number 8313878
Addre$8.' 56 Flandern Road London W4 1NG
Date: 0111012026

ststement of financlal activltles Year ended 31 December 2025
2025
Total
funds
2024
Total
funds
Unrestrktsd
fvnd5
Restricted
funds
Notes
Income:
Donatlons
Bank interest
Total Inrom•
53,486
245
53,731
101.105
154591
24
154,836
39,565
557
40.122
101.105
Expendture".
Expendltvre oft charltsble artI￿tIeS
Totsl •xpenditur•
152 628
IS2M8
56.523
96,105
42.057
Ilet ineome {eMpendlture}
Net movement In lunds
5,000
Recondll*lon of funds:
Funds brought fonvard at
l January 2024
17,836
17
19,777
Funds orrled forward at
31 December 2014
15,044
20O50
17,842
All ofthe above amounts resulted from the tharity'$ contlnulng act￿ltIeS durlngthe abover two
financial perlods,
The notes on pages 19 to 22 form part of these accounts

Balance sheet 31 December 2025
2025
2024
Notes
c￿￿ent assets:
Debtors
Cash at bank In hand
53,786
30.842
76.651
49.797
Uabllltles:
Credltors: amountsfalling due withln oneyear
-56.600 -31.9S5
Total net assels
20,051
17,842
Thefunds otthe ¢harltr.
Restrfcted funds
Unrestricted funds
General funds
Totalfunds
20.051
17,842
The note5 on pages 19 to 22 fom) part ofthese accounts

Statement of cash Ilows 31 December 2025
2024
Note5
(￿h Ilowslrorn operat1nzad1￿I1È￿'.
Netcash provlded by operating actsvitles
3.665
40,￿$
Bank Interestod receNed
24
557
Ch•ny In ¢a5h andrashequWThts Ihtheyt•r
3.910
-39.528
Cash and ￿5h equfvalentat lJanuary1025
495S
58,483
¢*h ahd Gjsh ¢qW¥w￿￿t4t$I I)e￿mber1025
2l865
1&955
Notss toth•¢•gh)lowststementforthe y•ar to Yi Deumb•r2014
A RewThtlM•tlon of thet mo¥em•rt In fund5 lo Tret ta5hllrbwfrom
x*
2024
mo¥emÈr>tin fundslas perstaremtnt offinantvdl att￿￿Es)
Intere$t receivablè
Decrease/llnerÈasel debtors
IDKrea5el in crtdkor5
N•tush ￿￿e0 byo r•tknEacthAdes
-L935
-557
11.587
3,665
An11￿&01￿3￿*s1n netd•èt
All
January
2025
At
han#e Deumbw
Year
21)25
Cash at bank ahd in hand
18,955
3.910
32,865

Principal accouting policies 31 December 2025
Basls of pieparatlon
The princlpalaccountlng policies adopted* judgements and keysources of estlmatlon uneertainty in
the preparation of the linanclal statements are laid out below.
8asls of accountlng
These accounts have been preparedforthe yearto 31 December 2025.
The accounts have been prepared underthe historlcal cost convention wth items initlally recognise(J
al cost ortransactionvalue unless Othemise stsied in the relevant accountlng pollcles below or the
note5 to these accounts.
The accounts have been prepared In accor(lance wlth Accounting and Reporting by Charltles:
Statement ol Recommended Practlce applicable to charities preparingtheir accounts In accordan¢e
with Ihe Financial Reportlng Standard appllcable in the UKand Repubilc of Iieiand IFRS 1021
I'charitles SORP FRS 102,1 issued on 16 July2014, the Flnancial Reporting Standaid applicable in the
un￿e￿ Kingdom and Repubilc of Ireland IFRS 1021 andthe Charftles Act 2011.
The charfty constltute5 a pubife benefit entityas defined byFRS 102.
The accounts are presented in stertingand are rounijed to the nearest pound.
Crltlcal accountinge$timates and area$ of lud8ement
There are no items In ihe accounts %there Irustees have been requlred to make signilicantjudgements
an¢J estimates.
Assessment of golngcon¢ern
The trustees have assessed whether the use of the golng concern assumption is approprlate In
preparingthese accounts. The trustees have made this a$sessment in respect lo a perlod of one year
from the date of approval of these accounts.
The trustees of the charlty have concluded that there are no materlal uncertalntles related lo events or
conditions that maycast slgnlflcanl doubt on the abiL4tyof the charltylo contlnue as a goingconcern.
The trustees are of the opbnlon that the charity will have sufficient resources to meets rts liabilities as
they fall due. In makingihis assessment, tiustees have considered the impact of the coronaviw5
pandemic on the operatlonal and financial performance ofthe charity.
Funds struclure
Unre5tr1cted Income funds are those whlch the Trustees arefree to use for any purpose In furtheiance
ol the charitys objects. Unrestricted funds include designated funds, where the donor has made
known their non binding wishes orwhere the trustees èttheii discretion, have created the designatlon
lor a specific purpose, Restricted lun(Js arise from grants and donations recelved for specific purposes
definèd by the donor orthe terms of an appeal. Restricted funds relatingto Income received In
connection with the Aiilance Boots Blobank project are llanslerred to the Biobank projectlhrough
grants made to the EORTC.

Principal a¢coutin8 policles 31 December 2025
Incom8
All incoming iesources are recognised when the foiLowingihree factors are met".
l. entitlement-conlrol over the righttolhe economic beneflt has passed to the charity.
2. probable- it15 more likelythan nol thatthe economlc benefits associated wlth the transaction wlll
flow to the charlty.
3. measurement- when the monetaryvalue of the incomlng resources can be measured retlably.
Income comprises donations and bank interest.
Donations are recognised when the charfty has confirmation of both the amount and settiementdate.
Inteiest on funds held on deposit is Included when ieceivable and the amount can be measured
rellably by the charlty.. this Is normally upon notification of the interest paid or payable bythe bank.
Forelgn exchange
Item5 appearing in the accounts have been translated on the followlng bases:
Assets and liablllties- at rates prevailing atlhe balance shget date.
Income and expendlture.. at average rates forthe year.
Differences arislng on exchange are Charged or credlted to the Statement of FinancialActMties.
Expendllure
Liabilttles are recognlsed as expendltltre as soon as there Is a Legal or constructwe obligatlon
commtttlng the charityto make a paymentto a Ihird pèty, it is probable that a transfer of economic
benefits wlll be requlred in settlement and the amount of the obligation can be measured reliably.
All expendlture is accounted for on an a¢ciuals basls. Expenditure comprises direct Costs aniy support
costs. Ail expenses, including support costs. are allocated or apportioned to the appllcable
expenditure headings. The classificatton between activities Is as follows:
- Expendlture on raislnglunds Includes all expenditure associated wlth raislngfunds forlhe charity
Expendlture on charitable activities includes ali costs assoclaied wlth furtherlngthe charitable
PUTposes of the charltythrough the pYovi5ion of Its charftable actrvltles. Such costs include chaiiiabie
grants and donations, direct and support Costs and govemance costs.
Grants are made to the EORTC and to the EORTC Cancer Research and forfellowshlp5. A Ilabiutyfoi
such grants is recognised when approval has been given bythe frustees.

Prlncipal accoutln8 policle5 31 December 2025
Expendlture {contlnued}
Other¢05ts includes all expenditure that cannot be analysed into the abovetwo headlngs.
Contractual arrangements are recognised as goods and Ser￿CeS are supplied and ale accounted for
on an accruals basis.
IrrecoverableVAT Is charged agalnstthe category ot resources expended, forwhich It was Incurred.
Deblorg
Debtors are recogni$e(J attheir settlèment amount. less any provision for n0n-recoverabl1￿.
Prepayments are valued at the amount Prepaid.
Cash at bankand in hand
Cash at bankand in hand represents such accounts and instwments that are available on demand or
have a maturlty of less than thTee month5 from the date of acquisltlon. Deposits for more than three
months but less than one year have been disclosed as shor( term deposits. Cash placed on deposil for
more than one year is disc105ed as a fixed asset Investment.
Credltors and provlslons
Creditors and prO￿S1On5 are recognlsed when there is an obligation at the balance sheet date as a
result of a past event. ￿ Is probable that a transfei of economic benefit will be required In seittement,
anl the amount ofihe settlement can be estlmated ¥eliably. Creditors and provlslons are recognlsed
at the amountthe charltyantlclpate5 Itwlll payto settiethe debt.

Notes to the a¢counts 31 December 2025
Relatod partytr•wettotts
The Friends of EORTC provides finzncial supwjrtto the EORTC Cancer Researth Fund
and EOftTC. The Trustees tsf the Charity had tho followin8 connection5 wfth these
orBanlsafjonihrou8hout 2022 and 2025.
EORTtCantet fte5￿h Fund
Chairman Of1￿ Counell
Memberof thecoundl
Memberofthe Coundl
Diego dv Monreau de 8ergendal
Duntan Jodrell
Cèrollne knis
EORTC
Board member
Board member
Grants to EORTC are sh¢)wn In thote 3 below.
None of the tDJ5tee5 recefved paymerf forthelrsÈrvtw tothe (harity or relmbutsement of
expense5 bythe Chathv.
Donatlon%
Unre￿ricted
f¢Jnds
R•strfcted
tknnations from ind￿ldUal$ andlovndatlons
Corp)rate donafjDns
2025total funds
loo￿(￿) 153486
1,105
1.105
101.105 154,591
53.486
UnrestrKted
fund5
Restrlcted
funds
2024
Donations from IndNiduals and foundatbn5
Corporate don0￿0￿5
2025 totsl funds
39.529
39529
36
36
39.529
19,565
Chirlt•ble expenditur•
Unrestricted Restrkred
funds
fund5
Grants awarded
U?ison office and finance costs
Bad debt expense
96.105
96.105
53A41
53.442
G¢>vernance costs
Audit and accountingfres
Rentsl
B•n* and subscription char8es
2025 totsl funds
1.2(M)
1.281
56523
96,105 151618

Notes to the accounts 31 December 2025
3 Charltable expendlturÈ Icontinuedl
Unrestricted
funds
Restricted
funds
2024
Dlrect t05ts
Grants awarded
Liaison office and finance costs
Bad debt expense
36
36
39A79
39,479
Support costs
Governance costs
Audit and accounting fees
Bank and subscrlption charges
2024 total funds
1,21
1,342
42,021
L200
1,342
42,057
36
There are no key management personnnel employed by the charity.
4 Comparatlve Statement of Flnanclal Actlvftles
Unrestricted
Unrestricted
funds
Restrlcted
funds
2024
Notes
Income:
Donatlons
Bank Interest
Total income
39,529
557
40,086
36
39,565
557
40,122
36
Expenditure.,
Expenditure on tharitable activitie5
Total expenditure
42,021
42,021
36
36
42,057
42.057
Net income lexpendlturel
-1,935
-1.935
Net movement In funds
-1.935
-1,935
Reconciliation of funds..
Funds brou8ht forward at
l January 2024
19.771
19.777
Funds carried forward at
31 December 2024
17,836
17.842
5 0ebtOfS
2025
2024
Prepayments and other debtors
Gift Aid
53,786
30.842
53.786
30,842

Notes to the accounts 31 December 2025
6 Current Ilabilltles
2025
2024
Amounts failin8 due within one year:
Accruals
Debt EORTC
Trade credltors
2,343
816
53,441
56.600
31,955
31,955
7 Re$trlrted funds
The Income f(nds of the charity include ￿StrIcted funds comprising the following
unexpended balances.
Ati
At31
January Incomlng Resources December
2025
resources expended
2025
Americsource8ergen
E2-RadiatE
1,105
1,105
-1.105
-1.105
Atl
At31
January In¢oming Resources December
2024
resources expended
2024
Americsource8ergen
E2-RadiatE
36
-36
36
-36
AmericsourceBer8en
Donations received to this fund are be applied for tunding SPECTA18iobank 15531
E2-RadlatE
t>onatfjon5 recelved to this fund are be applied for fundlng E2-Radiate118111

Notes to the accounts 31 December 2025
8 Unre$trirted funds
Ati
At31
January Incoming Resouros December
2024
resources expended
2024
General funds
Total unrestTlrted funds
17.836
17,836
53,731
53,731
-56.523
-56.523
15,044
15,044
Atl
At31
January Incoming Resource5 D•¢ember
2024
resources expended
2024
General funds
Total unrestrirted funds
19,771
19,771
40,086
40.086
42.021
-42,021
17,836
17,836